ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.

Fan Y, Hou T, Dan W, Zhu Y, Liu B, Wei Y, Wang Z, Gao Y, Zeng J, Li L
Cell Death Differ. 2022 Aug;29(8):1611-1624. doi: 10.1038/s41418-022-00951-y. Epub 2022 Feb 22. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.